Issue Date: January 30, 2017 | Web Date: January 25, 2017
Ginkgo Bioworks buys DNA supplier Gen9
Synthetic biology firm Ginkgo Bioworks has acquired its DNA supplier Gen9 for an undisclosed amount. As a result, Gen9’s capabilities for synthesizing large amounts of DNA now directly feed into Ginkgo’s automated organism-engineering foundries.
Ginkgo uses the DNA to build customized multigene enzymatic pathways and microbial strains for clients such as Cargill and Archer Daniels Midland that are looking to produce chemicals and ingredients. In 2016, Gingko signed DNA . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society